Zachary H. Hopkins, MD; Amber Jimenez, MD; Vanina L. Taliercio, MD, MS; et al.
JAMA Dermatol. 2023;159(11):1185-1194. doi:10.1001/jamadermatol.2023.3121
This cross-sectional study investigates the Skindex-16 score as a skin-related quality of life measure in autoimmune bullous disease subtypes during flare and nonflare states and evaluates Skindex-16 construct validity.
Sarah B. Bateni, MD, MAS; Paul Nguyen, PhD; Antoine Eskander, MD, MSc; et al.
open access
JAMA Dermatol. 2023;159(11):1195-1204. doi:10.1001/jamadermatol.2023.3179
This cohort study compares costs, survival, and time toxicity among patients with melanoma in 2007 to 2012 vs 2018 to 2019.
Danielle Rodriguez, PhD; Shawn G. Kwatra, MD; Carla Dias-Barbosa, MSc; et al.
open access
JAMA Dermatol. 2023;159(11):1205-1212. doi:10.1001/jamadermatol.2023.3251
This qualitative study of patients with severe prurigo nodularis describes their perspectives on their symptoms and how the disease affects their quality of life.
Neel M. Helvind, MD, PhD; Marie Brinch-Møller Weitemeyer, MD; Annette H. Chakera, PhD; et al.
free access
JAMA Dermatol. 2023;159(11):1213-1222. doi:10.1001/jamadermatol.2023.3256
This retrospective cohort study estimates stage-specific recurrence and melanoma-specific mortality rates, estimates absolute stage-specific risks of recurrence and mortality, and describes stage-specific recurrence patterns in Danish patients.
Soo Ick Cho, MD, PhD; Cristian Navarrete-Dechent, MD; Roxana Daneshjou, MD, PhD; et al.
JAMA Dermatol. 2023;159(11):1223-1231. doi:10.1001/jamadermatol.2023.3521
This diagnostic study builds synthetic data sets for diagnosing melanoma and melanocytic nevus with artificial intelligence (AI) using unstandardized photographs on the internet.
Katharina S. Shaw, MD; Tyler T. Nguyen, BS; Ahmad Rajeh, BS, MS; et al.
JAMA Dermatol. 2023;159(11):1232-1239. doi:10.1001/jamadermatol.2023.3649
This cohort study assesses whether tracking 3-dimensional stereophotogrammetry–generated facial heat maps over time could illustrate clinically meaningful disease progression in patients with craniofacial morphea.
Celeste M. Boesjes, MD; Lian F. van der Gang, MD; Daphne S. Bakker, MD, PhD; et al.
JAMA Dermatol. 2023;159(11):1240-1247. doi:10.1001/jamadermatol.2023.3849
This case series presents and describes 11 patients with atopic dermatitis who developed a lymphoid reaction during treatment with dupilumab.